SARAH CONN: Open Payments
NPI 1225798481 · SAINT ALBANS, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 62 payments from 10 companies in 2025. Trend: 2023 $142 · 2024 $179 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $435 |
| ABBVIE INC. | 14 | $217 |
| Novo Nordisk Inc | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Vertex Pharmaceuticals Incorporated | 1 | $21 |
| Insulet Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: CAPLYTA, QULIPTA, VRAYLAR, FANAPT, GEMTESA, Cologuard Collection Kit, FREESTYLE LIBRE 2, JOURNAVX.
Industry payments across WV — which companies pay providers there.
